Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering the Innovation Grants to Nurture Initial Translational Efforts (IGNITE) program, aimed at supporting the development of assays and the identification of therapeutic agents for neurological disorders and diseases. This initiative seeks applications to create in vitro, ex vivo, or in vivo assays and conduct screening efforts to identify potential therapeutic agents, particularly focusing on non-opioid analgesics with minimal addiction liability, as part of the NIH Helping to End Addiction Long Term (HEAL) initiative. Eligible applicants include various organizations such as Indian/Native American Tribal Governments, federal agencies, and non-domestic entities, with no cost-sharing or matching requirement. Interested parties can reach out to NINDS_IGNITE@nih.gov for further information, and while applications are not currently being solicited, the estimated synopsis post date is July 30, 2026, with a close date of September 30, 2026, and an anticipated award date of July 1, 2027.
Eligible Applicants
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).